Both groups used activated ErbB2 models of tumourigenesis in Akt1-/- and Akt+/+ backgrounds and demonstrated the importance of Akt1 in mediating ErbB2-induced tumourigenesis: mice lacking Akt1 either failed to develop tumours or tumourigenesis was delayed. Here, ERBB2 is linked to neoplasm.